Comprehensive management of dog faeces: Composting versus anaerobic digestion.

The objective of this work was to study the possibilities to manage and recycle dog faeces (DF) using biological processes, using two approaches: composting (C) and anaerobic digestion (AD). Thus, different experiments have been carried out: i) two laboratory/pilot scale experiments (self-heating and composting tests) and one, on a commercial scale; ii) two AD experiments. In both approaches, municipal waste such as the organic fraction of municipal solid waste (OMSW) and urban pruning waste (GW) were used as co-substrates. The results obtained regarding the optimization of the composting process indicated that the best strategy was the use of a 1:2 ratio of DF, a 1:4 ratio of OMSW, and a 1:4 ratio of GW, according to the thermal parameters studied (temperature and cumulative quadratic exothermic index (EXI2)), and the quality of the compost obtained. A potentially limiting factor of the process was the high salinity of the DF waste. In addition, AD experiments were performed on DF, OMSW, and GW wastes in controlled anaerobic systems at a laboratory scale. In these experiments, the biogas production obtained was 229 mL biogas/g total solids for the DF residue, 248 mL biogas/g total solids for GW, and 263 mL biogas/g total solids for OMSW. The co-digestion yields a clear improvement in the efficiency of the process against the use of a single residue, increasing the production of biogas by up to 27% with respect to that of the DF waste alone during the first 25 days of AD. The results obtained with these procedures have shown the possibilities to add value to this waste in an urban context where the circular economy represents an increasingly favourable scenario, including the generation of fertilisers and/or energy at a local scale, provided that the collection of dog faeces is optimized.

Frequency of human platelet antigens (HPA)-1, -2, -5 and -15 in Brazilian blood donors and establishment of a panel of HPA-typed donors.

OBJECTIVES: The aim of this study is to keep a record of regular human platelet antigens (HPA)-typed blood donors and to compare their allele frequencies with those reported in other populations. BACKGROUND: HPA are polymorphisms expressed on platelet membrane glycoproteins. They can generate an immune response leading to platelet alloimmunisation that may show clinical manifestations, such as neonatal alloimmune thrombocytopenia, post-transfusion purpura and platelet refractoriness. Platelet alloimmunisation is not uncommon, therefore, for an optimum management, it is advantageous to establish a panel of typed platelets to help matched platelets selection in HPA-alloimmunised patients transfusion. METHODS: The polymerase chain reaction (PCR)-allele-specific primers and PCR-restriction fragment length polymorphism methods were used to determine the genotypes of HPA-1, -2, -5 and -15 systems of 337 blood donors. RESULTS: The three genotypes (AA, AB and BB) were found in all HPA systems analysed, and the most frequent genotypes were AA for HPA-1, -2 and -5 systems (mean: 0·732) and AB for HPA-15 system (mean: 0·523). Allele frequencies were 0·148, 0·155, 0·140 and 0·430 for HPA-1b, -2b, -5b and -15b, respectively, and they were similar to those found in Caucasian populations, especially for HPA-1. However, the B allele was more frequent in all HPA systems when compared with Amazon Indians, and the frequency of the B allele in our study was higher in HPA-1 and -15 systems and lower in HPA-2 and -5 systems in comparison with sub-Saharan African populations. CONCLUSIONS: A record of HPA-typed donors would enable rapid identification and selection of donors when HPA-compatible platelets are required for transfusion.

[Short bowel syndrome cause of hypomagnesaemia importance of its diagnosis and treatment]. / Síndrome de intestino corto causa de hipomagnesemia, importancia de su diagnostico y tratamiento.

The short bowel syndrome (SIC) is a complex entity characterized by a malabsorptive state usually secondary to extensive intestinal resection originating a clinical, metabolic and/or nutritional disorder due to the reduction of the effective intestinal absorptive surface. The diagnosis is essentially clinical and, due to the patients malabsorptive process, it requires nutritional support to maintain their basic requirements, as the case reported. The clinical features of SIC patients depend on the grade of the alteration of function of the the small intestine or the impairment secondary to the surgical resection. We know that electrolytes are absorbed predominantly in the proximal gut. The regulation of ion/mineral levels depend on both the intestinal absorption and the renal excretion. We present an unusual case of SIC with only low absorption of magnesium. We discuss the most outstanding aspects of the case and review the literature.

El síndrome de intestino corto (SIC) es una entidad compleja caracterizada, por un estado malabsortivo secundario normalmente a una resección intestinal extensa que ocasiona alteraciones clínico, metabólicas y/o nutricionales debidas a la reducción de la superficie absortiva intestinal efectiva. El diagnóstico es fundamentalmente clínico y el paciente, por el proceso malabsortivo, requiere un soporte nutricional para mantener sus requerimientos básicos, como en el caso que presentamos. La clínica asociada al SIC también está en función de la zona de intestino delgado afectada por la resección o la alteración funcional. Sabemos que los electrolitos son absorbidos predominantemente en el intestino delgado. La regulación de los niveles de iones/minerales se basa tanto en la absorción intestinal como en la excreción renal. Consideramos de interés la publicación del caso, dado lo excepcional de la pérdida aislada de magnesio secundaria al SIC. Comentamos los aspectos más destacables del mismo y revisamos la literatura.

Novel polymorphisms in the promoter region of the perforin gene among distinct Brazilian populations and their functional impact.

Cytotoxic T lymphocytes and natural killer cells play a crucial role in eliminating tumour and virus-infected cells. The perforin is a key part of the arsenal that these cells use to destroy their targets. In this study, we characterized single-nucleotide polymorphisms (SNPs) located in the promoter region of the perforin gene among distinct Brazilian ethnic groups. The study was carried out by sequencing this region in three groups: European, African and Asian descents. We demonstrated for the first time the occurrence of three new polymorphisms in the promoter region of gene PRF1: 494A/G (rs78058707), 720G/A (rs75925789) and 1176C/T (rs75183511). Three other SNPs already described in the literature 63A/G (rs35401316), 112A/G (rs10999428) and 1012C/T (rs35069510) were also detected. The SNPs are distributed differently in the ethnic groups studied. The 112G allele was observed at high frequency, especially among Asian descents (48.1%). The 1012T allele was detected only among European descents, the 494G allele only among Asian descents and 1176T allele only in African descents. Based on the association between the polymorphisms described, ten new haplotypes were originated. In functional analysis, we noticed that SNPs present in most common haplotypes cannot induce significant differences in expression levels of perforin alone. In conclusion, this study demonstrates for the first time the existence of three new polymorphisms in perforin promoter and, contrary to what was stated, the presence of these SNPs does not alter the levels of protein expression.

[Update on gamma-hydroxybutyric acid]. / Actualización del ácido gamma-hidroxibutírico.

AIMS: The article offers an updated review of the main pharmacological aspects of gamma-hydroxybutyric acid (GHB), as well as its clinical and behavioural effects. DEVELOPMENT: A number of pharmacological, neurochemical and electrophysiological studies have clearly shown that endogenous GHB plays a role as a neurotransmitter and/or neuromodulator in the central nervous system (CNS). GHB displays specific synthesis, release and reuptake mechanisms, as well as particular binding sites that suggest the existence of a central GHBergic system. This substance, popularly known as 'liquid ecstasy', is also a potentially abusable drug; if administered for prolonged periods of time it can lead to dependence and withdrawal symptoms after the patient stops taking it. Its chief behavioural actions include sedation/sleepiness, induction of absence seizures, catalepsy or reduced aggression, among others. Some of these effects appear to be related to an interaction that has been reported to exist between the GHBergic system and the dopaminergic and GABAergic receptors in the CNS. From the clinical point of view, its use has been approved in some countries to treat the narcoleptic syndrome, and it has also been considered for possible use in the treatment of alcohol or opiate abuse. Finally, recent studies conducted with laboratory animals suggest the existence of a possible neurotoxic effect following prolonged administration in abusable dosages. CONCLUSIONS: GHB is an extraordinarily interesting compound. It acts as a neurotransmitter/neuromodulator in the CNS. It is also an abusable recreational drug and may also be used to treat a number of different pathological conditions, the most important of which is narcolepsy. The possible development of neurotoxicity following prolonged administration, however, imposes considerable limitations on its usefulness in clinical contexts.

M-mode omnidirectional recordings obtained from two-dimensional echocardiography.

A simple and inexpensive procedure to obtain M-mode tracings at any level or direction from two-dimensional echocardiograms is described. The method permits a complete M-mode visualization of 1) segmental motion of the cardiac walls, 2) structures difficult to reach with conventional procedures, and 3) two or more cardiac valves simultaneously.